Extrawell Pharmaceutical Holdings マネジメント
マネジメント 基準チェック /34
現在、CEO に関する十分な情報がありません。
主要情報
Yi Xie
最高経営責任者
HK$1.4m
報酬総額
| CEO給与比率 | 94.9% |
| CEO在任期間 | 10.9yrs |
| CEOの所有権 | n/a |
| 経営陣の平均在職期間 | データなし |
| 取締役会の平均在任期間 | 13.5yrs |
経営陣の近況
Recent updates
Here's Why Extrawell Pharmaceutical Holdings (HKG:858) Can Afford Some Debt
Mar 18
Extrawell Pharmaceutical Holdings (HKG:858) Is Making Moderate Use Of Debt
Dec 01We Think That There Are Some Issues For Extrawell Pharmaceutical Holdings (HKG:858) Beyond Its Promising Earnings
Aug 04Is Extrawell Pharmaceutical Holdings (HKG:858) Using Debt Sensibly?
Mar 15Some Shareholders May Object To A Pay Rise For Extrawell Pharmaceutical Holdings Limited's (HKG:858) CEO This Year
Aug 20CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | HK$1m | HK$1m | -HK$163m |
| Dec 31 2023 | n/a | n/a | -HK$159m |
| Sep 30 2023 | n/a | n/a | -HK$154m |
| Jun 30 2023 | n/a | n/a | -HK$13m |
| Mar 31 2023 | HK$1m | HK$1m | HK$129m |
| Dec 31 2022 | n/a | n/a | HK$109m |
| Sep 30 2022 | n/a | n/a | HK$88m |
| Jun 30 2022 | n/a | n/a | HK$109m |
| Mar 31 2022 | HK$1m | HK$1m | HK$131m |
| Dec 31 2021 | n/a | n/a | HK$12m |
| Sep 30 2021 | n/a | n/a | -HK$107m |
| Jun 30 2021 | n/a | n/a | -HK$114m |
| Mar 31 2021 | HK$1m | HK$1m | -HK$121m |
| Dec 31 2020 | n/a | n/a | HK$6m |
| Sep 30 2020 | n/a | n/a | HK$133m |
| Jun 30 2020 | n/a | n/a | HK$108m |
| Mar 31 2020 | HK$1m | HK$1m | HK$83m |
| Dec 31 2019 | n/a | n/a | HK$73m |
| Sep 30 2019 | n/a | n/a | HK$63m |
| Jun 30 2019 | n/a | n/a | HK$63m |
| Mar 31 2019 | HK$1m | HK$1m | HK$64m |
| Dec 31 2018 | n/a | n/a | HK$51m |
| Sep 30 2018 | n/a | n/a | HK$39m |
| Jun 30 2018 | n/a | n/a | HK$34m |
| Mar 31 2018 | HK$1m | HK$1m | HK$30m |
報酬と市場: Yiの 総報酬 ($USD 178.05K ) は、 Hong Kong市場 ($USD 233.11K ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Yiの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Yi Xie (61 yo)
10.9yrs
在職期間
HK$1,386,000
報酬
Dr. Yi Xie, Ph.D. serves as the Chief Executive Officer of Extrawell Pharmaceutical Holdings Ltd. Dr. Xie is one of the founders of United Gene group of companies in the PRC. Dr. Xie is responsible for res...
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chairman & CEO | 10.9yrs | HK$1.39m | データなし | |
| Executive Director | 16.1yrs | HK$557.00k | データなし | |
| Deputy CEO & Executive Director | 10.9yrs | HK$713.00k | 6.14% HK$ 7.9m | |
| Executive Director | 1.6yrs | データなし | データなし | |
| Company Secretary & Executive Director | 16.1yrs | HK$940.00k | データなし | |
| Honorary Chairman and Chief Scientific Advisor | no data | データなし | 7.95% HK$ 10.3m | |
| Independent Non-Executive Director | 23.8yrs | HK$70.00k | データなし | |
| Independent Non-Executive Director | 20.2yrs | HK$70.00k | データなし | |
| Independent Non-Executive Director | less than a year | データなし | データなし |
13.5yrs
平均在職期間
61yo
平均年齢
経験豊富なボード: 858の 取締役会 は経験豊富で 経験豊富 です ( 13.5年の平均在任期間)。